The Patent Finder

Method of Administering Amantadine Prior to a Sleep Period

Adamas Pharma, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/266,053, filed Dec 2, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,741,343Method of Administering Amantadine Prior to a Sleep Period
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
US 9,867,791Method of administering amantadine prior to a sleep period
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
US 9,867,792Method of administering amantadine prior to a sleep period
In force
 · Medium confidence
Adamas Pharma, LLCIn force
Medium confidence
US 9,867,793Method of administering amantadine prior to a sleep period
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
US 9,877,933Method of administering amantadine prior to a sleep period
In force
 · High confidence
Adamas Pharma, LLCIn force
High confidence
US 11,197,835Method of administering amantadine prior to a sleep period
In force
 · Medium confidence
Adamas Pharma, LLCIn force
Medium confidence
Application 14/863,035Amantadine Compositions and Methods of Use
Abandoned
Abandoned Aug 25, 2017
Adamas Pharma, LLCAbandonedAbandoned Aug 25, 2017
Application 15/428,920Amantadine Compositions and Methods of Use
Abandoned
Abandoned Nov 30, 2018
Adamas Pharma, LLCAbandonedAbandoned Nov 30, 2018
Application 15/428,946Amantadine Compositions and Methods of Use
Abandoned
Abandoned Nov 19, 2018
Adamas Pharma, LLCAbandonedAbandoned Nov 19, 2018
Application 15/985,300Amantadine Compositions and Methods of Use
Abandoned
Abandoned Apr 29, 2020
Adamas Pharma, LLCAbandonedAbandoned Apr 29, 2020
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Adamas Pharma, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited